151 related articles for article (PubMed ID: 32940235)
1. Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis.
Kapoor R; So JBY; Zhu F; Too HP; Yeoh KG; Yoong JS
Value Health; 2020 Sep; 23(9):1171-1179. PubMed ID: 32940235
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk.
Zhou HJ; Dan YY; Naidoo N; Li SC; Yeoh KG
PLoS One; 2013; 8(12):e83959. PubMed ID: 24386314
[TBL] [Abstract][Full Text] [Related]
3. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
Saumoy M; Schneider Y; Shen N; Kahaleh M; Sharaiha RZ; Shah SC
Gastroenterology; 2018 Sep; 155(3):648-660. PubMed ID: 29778607
[TBL] [Abstract][Full Text] [Related]
4. Comparing endoscopy and upper gastrointestinal X-ray for gastric cancer screening in South Korea: a cost-utility analysis.
Chang HS; Park EC; Chung W; Nam CM; Choi KS; Cho E; Cho WH
Asian Pac J Cancer Prev; 2012; 13(6):2721-8. PubMed ID: 22938448
[TBL] [Abstract][Full Text] [Related]
5. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.
Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G
JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of
Kowada A
Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
[No Abstract] [Full Text] [Related]
7. Endoscopic screening for gastric cancer.
Dan YY; So JB; Yeoh KG
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
[TBL] [Abstract][Full Text] [Related]
8. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
Kowada A
Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population.
So JBY; Kapoor R; Zhu F; Koh C; Zhou L; Zou R; Tang YC; Goo PCK; Rha SY; Chung HC; Yoong J; Yap CT; Rao J; Chia CK; Tsao S; Shabbir A; Lee J; Lam KP; Hartman M; Yong WP; Too HP; Yeoh KG
Gut; 2021 May; 70(5):829-837. PubMed ID: 33028667
[TBL] [Abstract][Full Text] [Related]
10. International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk.
Ascherman B; Oh A; Hur C
Gastric Cancer; 2021 Jul; 24(4):878-887. PubMed ID: 33595744
[TBL] [Abstract][Full Text] [Related]
11. Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States.
Shah SC; Canakis A; Peek RM; Saumoy M
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3026-3039. PubMed ID: 32707341
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584
[No Abstract] [Full Text] [Related]
14. Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.
Wu JT; Zhou J; Naidoo N; Yang WY; Lin XC; Wang P; Ding JQ; Wu CB; Zhou HJ
Asia Pac J Clin Oncol; 2016 Dec; 12(4):359-368. PubMed ID: 27452189
[TBL] [Abstract][Full Text] [Related]
15. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study.
Huang HL; Leung CY; Saito E; Katanoda K; Hur C; Kong CY; Nomura S; Shibuya K
BMC Med; 2020 Sep; 18(1):257. PubMed ID: 32921305
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea.
Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC
Asian Pac J Cancer Prev; 2013; 14(4):2533-40. PubMed ID: 23725170
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
18. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of risk-based breast cancer screening programme, China.
Sun L; Legood R; Sadique Z; Dos-Santos-Silva I; Yang L
Bull World Health Organ; 2018 Aug; 96(8):568-577. PubMed ID: 30104797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
